Basal Health vs Hims
Basal Health and Hims sell different medications; this is what separates them.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Basal Health
Best for: coverage in all 50 states, which most sellers will not confirm
Visit Basal Health →
Hims
Best for: knowing which pharmacy fills the vial: it names Apostrophe Pharmacy LLC
Visit Hims →If you are choosing between Basal Health and Hims, price alone will not settle it. Hims leads our six-part score, 6.8 to 4.7. One of the two has an FDA warning letter on record, covered below.
Basal Health vs Hims price
Hims publishes $199 a month. Basal Health does not post a GLP-1 price we can quote, so you would only learn its cost after an intake.
Medications and formats
Hims lists semaglutide and tirzepatide; Basal Health does not name its drug.
On format, Basal Health posts no priced format, while Hims prices compounded injections and brand-name pens.
If you want the FDA-approved brand rather than a compounded version, Hims is the only one of the two with a brand-name price.
Where each one treats patients
Basal Health lists 50 states, and Hims lists 50 states.
They overlap in 50 states.
Pricing
Basal Health
Pricing not publicly listed.
Hims
Brand Zepbound from $299/mo medication-only; requires Hims Weight Loss Membership ($149/mo)
What each price covers
Both prices cover the medication itself.
Basal Health's price also covers the clinician visit, which Hims does not claim.
Basal Health is silent on shipping, lab work and coaching.
Hims is silent on shipping and lab work.
Basal Health
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
Not stated
Lab work
Not stated
Coaching
Not stated
Hims
Covered by the monthly price
Medication
In the price
Clinician visits
Charged on top
Shipping
Not stated
Lab work
Not stated
Coaching
Charged on top
Where each one scores higher
Overall, Hims scores 6.8 and Basal Health 4.7 out of 10.
Basal Health is stronger on support (5.0 vs 3.0).
Hims is stronger on effectiveness (10.0 vs 5.0), user experience (8.0 vs 3.0) and trust & safety (7.0 vs 5.0).
Value and accessibility are within half a point.
Basal Health
4.7/10
Hims
6.8/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
FDA warning letters
The FDA sent Hims a warning letter dated September 9, 2025 (letter 716567), and it is still open.
Basal Health has no FDA warning letter on record with us.
Features & Coverage
| Feature | Basal Health | Hims |
|---|---|---|
| Starting Price | Not published | $199/mo |
| Features | ✓5 features | 2 features |
| States Available | 50 | 50 |
| Compounded | — | ✓ Yes |
| Brand Name | — | ✓ Yes |
| FSA/HSA Accepted | — | — |
| FDA Warning Letters | ✓None | 1 letter |
About Basal Health
Three things go undisclosed: the GLP-1 molecules used, the pharmacy that fills the order, and the price. What Basal Health does describe is a metabolic-medicine framework in which the drug is one element of five markers under watch, body fat, VO2 max, hormonal response, muscle mass and insulin sensitivity, with dosing supervised by clinicians and adapted rather than fixed. The service covers all 50 states and DC.
Read our full Basal Health review →About Hims
Hims is a major men's telehealth brand. Its weight loss offering is compounded semaglutide on a 6-month plan.
Read our full Hims review →Pros & Cons
Basal Health
What we like
- The monthly price includes the medication and clinician visits
- Serves all 50 states
- We found no FDA warning letters issued to Basal Health
Watch-outs
- You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
- Ask which pharmacy fills the prescription before you pay, so you can check its license
Hims
What we like
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes the medication
- Serves all 50 states
- Names 4 pharmacies that fill its prescriptions, which most sellers do not
Watch-outs
- Not included in the monthly price: clinician visits, coaching
- The FDA has issued Hims a warning letter. Read what it alleges: a letter flags a problem but does not by itself rule a seller out
- Its semaglutide is compounded rather than FDA-approved, so it has not been reviewed by the agency for safety, effectiveness or manufacturing quality
Our Verdict
Hims wins this one, 6.8 to 4.7, above all for knowing which pharmacy fills the vial: it names Apostrophe Pharmacy LLC. Basal Health fits better if coverage in all 50 states, which most sellers will not confirm is your priority.
Choose Basal Health if…
You want coverage in all 50 states, which most sellers will not confirm.
Choose Hims if…
You want knowing which pharmacy fills the vial: it names Apostrophe Pharmacy LLC and an opening price near $199 a month.
Ready to start? GLP-1 providers we have vetted
Telehealth providers, vetted by us, prescribing GLP-1 online.
Vetted by our editors · no insurance required
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
DudeMeds
Compounded semaglutide at $175/month
From $175/mo
Get started →Oak
Semaglutide at $119/month, 37% below the typical price
From $119/mo
Get started →Trimi Health
Knowing which pharmacy fills the vial: it names VialsRx
From $99/mo
Get started →Basal Health vs Hims: FAQ
Close alternatives to Basal Health and Hims
- Basal Health vs Embody
- Basal Health vs TrimRx
- Basal Health vs Henry Meds
- Hims vs Hers
- Hims vs Care Bare Rx
- Hims vs Concierge MD LA
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.